2016
DOI: 10.1016/j.jss.2015.10.008
|View full text |Cite
|
Sign up to set email alerts
|

Interleukin 18–binding protein ameliorates liver ischemia–reperfusion injury

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 44 publications
0
3
0
Order By: Relevance
“…Takeuchi et al showed a significant reduction of IRI and a concomitant upregulation of anti-inflammatory cytokines such as IL-4 and IL-10 in a mice model under blockade of IL-18 [26]. In line with these results, Bal et al demonstrated a protective effect of IL-18binding protein on IRI induced liver injury in an experimental rat model [27]. Of note, our data showed similar kinetics of IL-18 and GGT perfusate concentrations (early increase, peak after 2 hours and decrease during ongoing perfusion) after prolonged SCS suggesting an association between IL-18 secretion and bile duct inflammation or injury.…”
Section: Discussionmentioning
confidence: 79%
“…Takeuchi et al showed a significant reduction of IRI and a concomitant upregulation of anti-inflammatory cytokines such as IL-4 and IL-10 in a mice model under blockade of IL-18 [26]. In line with these results, Bal et al demonstrated a protective effect of IL-18binding protein on IRI induced liver injury in an experimental rat model [27]. Of note, our data showed similar kinetics of IL-18 and GGT perfusate concentrations (early increase, peak after 2 hours and decrease during ongoing perfusion) after prolonged SCS suggesting an association between IL-18 secretion and bile duct inflammation or injury.…”
Section: Discussionmentioning
confidence: 79%
“…This indicates that the combination therapy of erythropoietin and methylprednisolone has advantages in inhibiting IL-1 and IL-8 and promoting IL-1RA, thereby ensuring better preservation of spinal nerve function. Moreover, these studies show that the combination of erythropoietin and methylprednisolone can significantly improve the quality of life of patients compared to therapy involving methylprednisolone alone [25,26].…”
Section: Discussionmentioning
confidence: 96%
“…The pathologic results revealed that a smaller hepatic artery diameter and a depressed vessel wall were observed at 30 minutes after reperfusion in the control group, and these results were not detected in other groups . This finding also provides strong evidence of the occurrence of a hepatic artery spasm.…”
Section: Discussionmentioning
confidence: 99%